• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0301
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Tissue Damage (2104)
Event Date 02/20/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the steerable guide catheter was discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the thrombus/septal tissue during the procedure.It was reported that this was a mitraclip procedure to treat grade 4 functional mitral regurgitation (mr).The steerable guide catheter (sgc) was advanced across the septum when thrombus was visualized on the dilator.The dilator was withdrawn into the sgc and the thrombus was aspirated.Additional information was received from the physician that what was originally thought to be thrombus may have been septal tissue upon crossing the septum.The sgc was removed and the device was flushed.Thrombus/septal tissue was flushed out in a bowl.A new sgc was used in the procedure.Two mitraclips were implanted reducing mr grade to trace.There was no adverse patient sequelae from the thrombus.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).The device was not returned for analysis.The reported patient effects of thrombosis and mitral valve injury (tissue damage) are listed in the mitraclip system instructions for use, as known possible complications associated with mitraclip procedures.Review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A definitive cause for the reported patient effects could not be determined and may be related to case circumstances, as the physician stated that what was originally thought to be thrombus may have been septal tissue upon crossing the septum; however, this could not be confirmed.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8422509
MDR Text Key138851381
Report Number2024168-2019-02029
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/08/2020
Device Catalogue NumberSGC0301
Device Lot Number90108U103
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/22/2019
Initial Date FDA Received03/14/2019
Supplement Dates Manufacturer Received03/26/2019
Supplement Dates FDA Received03/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-